CN1834233A - Preservative fluid for exfoliative cell - Google Patents
Preservative fluid for exfoliative cell Download PDFInfo
- Publication number
- CN1834233A CN1834233A CN 200610017591 CN200610017591A CN1834233A CN 1834233 A CN1834233 A CN 1834233A CN 200610017591 CN200610017591 CN 200610017591 CN 200610017591 A CN200610017591 A CN 200610017591A CN 1834233 A CN1834233 A CN 1834233A
- Authority
- CN
- China
- Prior art keywords
- parts
- preservative fluid
- edta
- ethylene diamine
- diamine tetraacetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
This invention discloses a preservation solution of exfoliated cells, which is composed of (by volume parts): methanol or ethanol 40-60, phosphate buffer solution or trihydroxymethyl aminomethane/HCl buffer solution 20-40, formaldehyde or acetone 5-10, and ethylenediamine tetraacetic acid dipotassium or Ethylenediamine tetraacetic acid disodium 5-10. This invention can reduce the cost of TCT consumable material by using inexpensive raw materials, and can reduce the consumption of consumable materials and time used on retreatment of the samples. This invention can keep the fixation of cells in reset conditions.
Description
Technical field
The present invention relates to a kind ofly, especially relate to a kind of exfoliated cell preservative fluid.
Background technology
Preservation liquid (the PreserveCyt of the present new Bai Shi of the U.S. (Tinpreper TCT) manufacturer production
TMSlution) be and the supporting patent reagent of its machine Tinpreper-2000, shortcoming: 1. cost an arm and a leg.2. flocks occurs after placing for some time for courageous and upright sample, operate the computer easy obstruction filtering net, cause film-making epithelial cell amount to reduce, therefore need to handle sample with Glacial acetic acid again and can go up machine.3. for the iuntercellular nucleus of piling up phenomenon appears increasing.
Summary of the invention
Purpose of the present invention just is that preserving the existing problem of liquid with regard to above-mentioned TCT improves: make it and can 1. reduce cost greatly.2. reduce flocculent precipitate, equal amount of bleeding and TCT preserve the liquid phase ratio.3. strengthen cell fixation, reduce nucleus and increase phenomenon.Thereby provide a kind of exfoliated cell preservative fluid of with low cost, better effects if.
Purpose of the present invention can realize by following measure:
The present invention is composed of the following components substantially, by volume part meter: 5 parts～10 parts of 40 parts～60 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or 20 parts～40 parts of Tutofusin tris hydrochloride buffers, formaldehyde or 5 parts～10 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention.EDTA-2K or disodium ethylene diamine tetraacetate preferred concentration are 10%.Certainly, also can adopt other suitable concentration.One-tenth is grouped into and also includes hemolytic agent, and hemolytic agent is cyaniding high ferro or bromo 16 alkyl Trimethylamine 99s, also can be other suitable hemolytic agents.
The present invention makes it to have following advantage owing to adopt above-mentioned prescription:
1, at first can reduce the price of TCT consumptive material, because above-mentioned starting material are common biochemical reagents, cost is low. and secondly can reduce and go out the dissatisfied rate of blood specimen for the first time, reduce the consumption and the waste of time of the consumptive material handle sample again and brought. because penetration power forces cell fixation abundant, keep cell fixing under virgin state as far as possible.
| Import Tnpreper TCT protects liquid | Protection liquid of the present invention | |
| Hemoglobin absorption degree cell aggregation amount sample disposal rate behind the courageous and upright sample floss of the price 30 μ l haemolysis | 60 yuan/person-portion many more than 0.19 11.8% | 10 yuan/person-portion few 0.27 few 4.8% |
Hemolytic agent: HiCN (cyaniding high ferro/bromo 16 alkyl Trimethylamine 99s
2,1. reduce cost greatly.2. reduce flocculent precipitate, equal amount of bleeding and TCT preserve the liquid phase ratio.3. strengthen cell fixation, reduce nucleus and increase phenomenon.
Embodiment
The present invention does with detailed description below in conjunction with drawings and Examples:
Embodiment 1, the present invention are grouped into by following one-tenth substantially, by volume part is counted: methyl alcohol or ethanol (concentration 95-100%, as follows) 5 parts of 40 parts, phosphate buffered saline buffer or 20 parts of Tutofusin tris hydrochloride buffers (Tris/HCl damping fluid, as follows), formaldehyde or 5 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.More than each constituent concentration can adopt conventional concentration (as follows).
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention, and preferred concentration is 10%.One-tenth is grouped into and also includes hemolytic agent, and hemolytic agent is cyaniding high ferro or bromo 16 alkyl Trimethylamine 99s, also can be other suitable hemolytic agents.Hemolytic agent by volume part is 5 parts.
Embodiment 2,
The present invention is grouped into by following one-tenth substantially, meter by volume part: 7 parts of 25 parts of 45 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or Tutofusin tris hydrochloride buffers (Tris/HCl damping fluid, as follows), formaldehyde or 7 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention, and preferred concentration is 10%.One-tenth is grouped into and also includes hemolytic agent, and hemolytic agent is cyaniding high ferro or bromo 16 alkyl Trimethylamine 99s, also can be other suitable hemolytic agents.Hemolytic agent by volume part is 8 parts.
Embodiment 3,
The present invention is grouped into by following one-tenth substantially, meter by volume part: 8 parts of 30 parts of 50 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or Tutofusin tris hydrochloride buffers (Tris/HCl damping fluid, as follows), formaldehyde or 8 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention, and preferred concentration is 10%.One-tenth is grouped into and also includes hemolytic agent, and hemolytic agent is cyaniding high ferro or bromo 16 alkyl Trimethylamine 99s, also can be other suitable hemolytic agents.Hemolytic agent by volume part is 15 parts.
Embodiment 4,
The present invention is grouped into by following one-tenth substantially, meter by volume part: 9 parts of 35 parts of 55 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or Tutofusin tris hydrochloride buffers (Tris/HCl damping fluid, as follows), formaldehyde or 9 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention, and preferred concentration is 10%.
Embodiment 5,
The present invention is grouped into by following one-tenth substantially, meter by volume part: 10 parts of 40 parts of 60 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or Tutofusin tris hydrochloride buffers (Tris/HCl damping fluid, as follows), formaldehyde or 10 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40% among the present invention, and preferred concentration is 10%.
In the mentioned component parameter value of each component can be as required in its value range value arbitrarily.
Claims (6)
1, a kind of exfoliated cell preservative fluid, it is characterized in that: it is grouped into by following one-tenth substantially, by volume part meter: 5 parts～10 parts of 40 parts～60 parts of methyl alcohol or ethanol, phosphate buffered saline buffer or 20 parts～40 parts of Tutofusin tris hydrochloride buffers, formaldehyde or 5 parts～10 parts in acetone, EDTA-2K or disodium ethylene diamine tetraacetate.
2, exfoliated cell preservative fluid according to claim 1 is characterized in that: described EDTA-2K or disodium ethylene diamine tetraacetate concentration are 5%～40%.
3, exfoliated cell preservative fluid according to claim 1 and 2 is characterized in that: described EDTA-2K or disodium ethylene diamine tetraacetate preferred concentration are 10%.
4, exfoliated cell preservative fluid according to claim 1 and 2 is characterized in that: described one-tenth is grouped into that also to include hemolytic agent part be 5 parts-15 parts by volume.
5, exfoliated cell preservative fluid according to claim 4 is characterized in that: described hemolytic agent is the cyaniding high ferro.
6, exfoliated cell preservative fluid according to claim 4 is characterized in that: described hemolytic agent is bromo 16 alkyl Trimethylamine 99s.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100175919A CN100500835C (en) | 2006-03-31 | 2006-03-31 | Preservative fluid for exfoliative cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100175919A CN100500835C (en) | 2006-03-31 | 2006-03-31 | Preservative fluid for exfoliative cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1834233A true CN1834233A (en) | 2006-09-20 |
| CN100500835C CN100500835C (en) | 2009-06-17 |
Family
ID=37002130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100175919A Expired - Fee Related CN100500835C (en) | 2006-03-31 | 2006-03-31 | Preservative fluid for exfoliative cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100500835C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953334A (en) * | 2010-08-30 | 2011-01-26 | 南京卡博生物科技有限公司 | Cell preserving fluid for liquid-based cytologic diagnosis |
| CN101999343A (en) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | Cell preserving fluid and preparation method and use thereof |
| CN102318597A (en) * | 2011-08-19 | 2012-01-18 | 张雪云 | Liquid-based cell preservation liquid composite and preparation method thereof |
| CN103120153A (en) * | 2012-11-26 | 2013-05-29 | 刘召宏 | Exfoliative cells preserving fluid |
| CN104849122A (en) * | 2015-06-02 | 2015-08-19 | 蒋春亮 | Long-acting tumor tissue exudate sample preservation solution |
| CN105994252A (en) * | 2016-06-22 | 2016-10-12 | 杭州海世嘉生物科技有限公司 | Liquid-based thin cell preservation liquid and preparation method thereof |
| CN110250160A (en) * | 2019-05-31 | 2019-09-20 | 广西壮族自治区人民医院 | Liquid based cell preservative fluid |
| CN111670896A (en) * | 2020-04-28 | 2020-09-18 | 浙江大学医学院附属妇产科医院 | Neutral buffer tissue fixing solution |
| CN114208812A (en) * | 2021-12-22 | 2022-03-22 | 桂林优利特医疗电子有限公司 | Liquid-based cell preservation solution |
-
2006
- 2006-03-31 CN CNB2006100175919A patent/CN100500835C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953334A (en) * | 2010-08-30 | 2011-01-26 | 南京卡博生物科技有限公司 | Cell preserving fluid for liquid-based cytologic diagnosis |
| CN101999343A (en) * | 2010-10-26 | 2011-04-06 | 深圳华大基因科技有限公司 | Cell preserving fluid and preparation method and use thereof |
| CN101999343B (en) * | 2010-10-26 | 2013-11-06 | 深圳华大基因健康科技有限公司 | Cell preserving fluid and preparation method and use thereof |
| CN102318597A (en) * | 2011-08-19 | 2012-01-18 | 张雪云 | Liquid-based cell preservation liquid composite and preparation method thereof |
| CN102318597B (en) * | 2011-08-19 | 2013-04-03 | 张雪云 | Liquid-based cell preservation liquid composite and preparation method thereof |
| CN103120153A (en) * | 2012-11-26 | 2013-05-29 | 刘召宏 | Exfoliative cells preserving fluid |
| CN104849122A (en) * | 2015-06-02 | 2015-08-19 | 蒋春亮 | Long-acting tumor tissue exudate sample preservation solution |
| CN105994252A (en) * | 2016-06-22 | 2016-10-12 | 杭州海世嘉生物科技有限公司 | Liquid-based thin cell preservation liquid and preparation method thereof |
| CN105994252B (en) * | 2016-06-22 | 2019-07-02 | 杭州海世嘉生物科技有限公司 | A kind of Thinprep pap test saves liquid and preparation method thereof |
| CN110250160A (en) * | 2019-05-31 | 2019-09-20 | 广西壮族自治区人民医院 | Liquid based cell preservative fluid |
| CN111670896A (en) * | 2020-04-28 | 2020-09-18 | 浙江大学医学院附属妇产科医院 | Neutral buffer tissue fixing solution |
| CN114208812A (en) * | 2021-12-22 | 2022-03-22 | 桂林优利特医疗电子有限公司 | Liquid-based cell preservation solution |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100500835C (en) | 2009-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1834233A (en) | Preservative fluid for exfoliative cell | |
| US6521729B1 (en) | Monodisperse fluorine-containing synthetic polymer particles having a defined refractive index for use as standards and calibrators in flow cytometry | |
| Evans et al. | Adhesivity and rigidity of erythrocyte membrane in relation to wheat germ agglutinin binding. | |
| CN106317335B (en) | Molecularly imprinted polymer sensing material suitable for biological samples and preparation method thereof | |
| Chapman et al. | A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination | |
| CN103926189A (en) | Flow-cytometry-based method for rapidly measuring heterotrophic bacteria in eutrophic lake | |
| CN1928527A (en) | Functional nano-fiber based method for extracting and enriching pollutants in water | |
| CN104592446A (en) | Preparation method and application of nano fiber molecularly-imprinted polymer of tetracycline antibiotics | |
| EP2324350A1 (en) | Reference control for cell by cell analysis | |
| Pickup et al. | Transport of small molecules in swollen polymer beads | |
| CN104820102A (en) | Kit of detecting the content of Lp-PLA2 and CRP on the basis of chemiluminescence, and method and application thereof | |
| CN101042371A (en) | Rapid capturing detection method for hydroxy free radical | |
| CN103461320B (en) | An a kind of conserving liquid such as not grade for liquid base thin layer cast-off cells | |
| Yehia et al. | Synovial fluid analysis. | |
| Hughes et al. | Phenotypic reversion of ricin-resistant hamster fibroblasts to a sensitive state after coating with glycolipid receptors | |
| CN113009007B (en) | Method for detecting content of root-resisting agent in root-puncture-resistant material | |
| EP3112862A1 (en) | Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis | |
| WO2022051443A1 (en) | Preparation of nucleated rbc (nrbc) analogs for use as reference hematology controls in automated hematology analyzers | |
| Barer et al. | Quantitation of dye binding by cell monolayers in a microtiter system | |
| Rajulu et al. | Chemical resistance and tensile properties of epoxy/polymethyl methacrylate blend coated bamboo fibres | |
| CN1815235A (en) | Judging method for quantitative determination of endotoxin concentration in sumple | |
| LU102450B1 (en) | A device and method for testing the content of phthalic acid esters in gas | |
| CN101632918B (en) | Grafting fiber material with adsorptive action and use method thereof | |
| CN1252099C (en) | Use of methylacrylic acid_vinyl glycol dimethyl acrylate polymers | |
| Li‐de et al. | The microrheological changes in the course of erythrocyte senescence after phenylhydrazine injection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090617 Termination date: 20110331 |